AIM
GHDX

Ada Investment Management’s Genomic Health, Inc. GHDX Stock Holding History

Ada Investment Management’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$342K Buy
+9,709
New +$260K 0.23% 157

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 39.77% 1-Year Est. Return

Ada Investment Management's GHDX Position: Q4 2015 in Review

Ada Investment Management opened a new position in Genomic Health, Inc. (GHDX) in Q4 2015: 9,709 shares worth $342K. The stake represents 0.23% of the portfolio and ranks #157 among its holdings.

132 funds tracked by Wall St. Rank hold GHDX as of Q4 2015.

  • Ada Investment Management held 9,709 shares of Genomic Health, Inc. worth $342K as of Q4 2015.
  • Genomic Health, Inc. was a new Ada Investment Management position in Q4 2015.
  • Genomic Health, Inc. made up 0.23% of Ada Investment Management's portfolio in Q4 2015, its #157 holding.
  • 132 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2015.

Based on Ada Investment Management's 13F filing for Q4 2015, filed 19 Feb 2016.